Immunovant Inc. Common Stock vs Knight-Swift Transportation Holdings Inc. — how do they compare? Immunovant Inc. Common Stock trades at $30.01 (market cap $6.62B), while Knight-Swift Transportation Holdings Inc. trades at $65.16 (market cap $10.35B). The key difference: Knight-Swift Transportation Holdings Inc. is the larger of the two by market cap, and Knight-Swift Transportation Holdings Inc. pays a 1.26% dividend while Immunovant Inc. Common Stock pays none. Which is the better fit depends on your goals — on Pluang, investors hold Immunovant Inc. Common Stock for 0 Days and Knight-Swift Transportation Holdings Inc. for 0 Days on average.
| IMVT | KNX | |
|---|---|---|
Market Cap | $6.62B | $10.35B |
Volume | 1,131,364 | 2,161,869 |
Sector | Health | Industrials |
52-Week High | $44.96 | $82.45 |
52-Week Low | $17.03 | $41.68 |
Typical Hold Time | 0 Days | 0 Days |
Enterprise Value | $5.72B | $12.85B |
Dividend Yield | — | 1.26% |
Trailing returns across standard periods
What Pluang investors did over the last 30 days
Immunovant is a clinical-stage immunology company developing therapies for autoimmune diseases. Its pipeline includes anti-FcRn antibody candidates designed for subcutaneous administration.
Read more on IMVT →Knight-Swift provides truckload, less-than-truckload, logistics, and freight management services. It operates a large transportation network across North America.
Read more on KNX →